Digoxin Induced Dissolution of CTC Clusters

Clinical trial NCT03928210 · COMPLETED

Trial details

NCT number: NCT03928210
Sponsor: University Hospital, Basel, Switzerland
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Circulating Tumor Cells (CTCs)

Start date: 2020-07-08
Primary completion: 2023-12-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.